Alethiomics

Description: Alethiomics uses single-cell multi-omics to develop breakthrough treatments for blood cancers, focusing on myeloproliferative neoplasms (MPNs).

Country: UK

Based in: Headington

Founded: 2021

Funding Stage: Pre-Seed

Tags: ['Biotechnology', 'Therapeutics', 'Pharmaceutical Manufacturing']

Categories

Add insights to your inbox

We’ll send you content you’ll want to read- and put to use.

Details about how we process your information are available in our Privacy Policy.